These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test. Printz C Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486 [No Abstract] [Full Text] [Related]
43. [Aspects in quality assurance in gynecological cytology]. Hilgarth M Gynakologe; 1990 Dec; 23(6):312-8. PubMed ID: 2279705 [No Abstract] [Full Text] [Related]
44. Anticipating the impact of the new screening guidelines on cytology and molecular laboratories. Booth CN Cancer Cytopathol; 2013 May; 121(5):225-7. PubMed ID: 23281254 [No Abstract] [Full Text] [Related]
45. Liquid-based cytology test use by office-based physicians: United States, 2006-2007. Hing E; Saraiya M; Roland KB Natl Health Stat Report; 2011 Jun; (40):1-6. PubMed ID: 21692417 [TBL] [Abstract][Full Text] [Related]
46. [Cervical pap smears: techniques and clinical significance]. Lambert C Rev Med Liege; 1999 Apr; 54(4):303-7. PubMed ID: 10389474 [TBL] [Abstract][Full Text] [Related]
47. Is a liquid-based cytology more sensitive than a conventional Pap smear? Sigurdsson K Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613 [TBL] [Abstract][Full Text] [Related]
48. Overview of the cytology laboratory: specimen processing through diagnosis. Joste N Obstet Gynecol Clin North Am; 2008 Dec; 35(4):549-63; viii. PubMed ID: 19061816 [TBL] [Abstract][Full Text] [Related]
49. Pap smears in the Third World. Lahri S S Afr Med J; 2007 Jul; 97(7):474-5. PubMed ID: 17805441 [No Abstract] [Full Text] [Related]
50. Quality and liability issues with the Papanicolaou smear: the problem of definition of errors and false-negative smears. Davey DD Arch Pathol Lab Med; 1997 Mar; 121(3):267-9. PubMed ID: 9111115 [TBL] [Abstract][Full Text] [Related]
52. Errors in the use of the Pap smear. Hughes RR South Med J; 1972 May; 65(5):575-8. PubMed ID: 5027464 [No Abstract] [Full Text] [Related]
53. Improving the accuracy of Pap smears. Evans TC Postgrad Med; 1997 Sep; 102(3):63. PubMed ID: 9300017 [No Abstract] [Full Text] [Related]
54. Follow-up of unsatisfactory Papanicolaou test results. McGaraghan A; Smith-McCune K JAMA; 2000 Mar; 283(10):1290-1. PubMed ID: 10714724 [No Abstract] [Full Text] [Related]
55. George Papanicolaou (1883-1962): Discoverer of the Pap smear. Tan SY; Tatsumura Y Singapore Med J; 2015 Oct; 56(10):586-7. PubMed ID: 26512152 [No Abstract] [Full Text] [Related]
57. Incidence of cervical cancer in perimenopausal and postmenopausal women detected by Papanicolaou smears. Neighbor RM; Newman RL Am J Obstet Gynecol; 1976 Feb; 124(4):348-51. PubMed ID: 1251855 [TBL] [Abstract][Full Text] [Related]
58. ABC3 and LBC - adequate or not? Duvall E Cytopathology; 2013 Aug; 24(4):211-5. PubMed ID: 23869916 [No Abstract] [Full Text] [Related]
59. New Pap test terminology, management guidelines published. Twombly R J Natl Cancer Inst; 2002 Jun; 94(12):878-80. PubMed ID: 12072539 [No Abstract] [Full Text] [Related]
60. Quality assurance in cervical cytology. The Papanicolaou smear. Council on Scientific Affairs. JAMA; 1989 Sep 22-29; 262(12):1672-9. PubMed ID: 2671421 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]